Date: Friday 17th March 2023 Time: 13:00-14:00 GMT Speakers: Christine Fletcher (GSK), Christy Mazzarisi (Mersana) and Paul Frewer (AstraZeneca).
Who is this event intended for? Anyone interested in learning about or developing leadership skills in the modern day hybrid working world. What is the benefit of attending? This session will cover the successes, challenges and changes needed by our leaders and managers in order to best support the changing workforce, whether that be in the office, remote working or a combination of the two.
Registration
Registration for this webinar is free, and is now open to Members of PSI and Non-Members. We'd love for you to join us!
To register for this event, please click here.
Overview
This PSI Lunch & Learn series focuses on career-related topics through a panel discussion, hosted by Claire Brittain & Chetan Mistry.
Upcoming session: In the upcoming event - "Modern Leaders: Remote not Distant" - we will be discussing the need for a conscious evolution of leadership styles as remote working becomes commonplace.
Whilst there has been a lot of debate on office-based vs. remote workers, there has been less discussion on what 'good' leadership looks like in the new working world. This panel discussion will explore how leaders in our industry have had to adapt, adjust and evolve in order to remain effective in their roles.
Speaker details
Speaker
Biography
Christy Mazzarisi
Innovative and accomplished Quality Systems Professional with a broad background in Pharmaceutical and Laboratory sciences with over 17 years industry practice. Overall background includes building and leading global teams across functions in the biotech and pharmaceutical space. She is passionate about continuous improvement activities and consistently building quality into each area of our lives by providing coaching, mentoring and professional support to team members, employees, and many others across industries who want to develop their leadership skills. Chair of Women in Quality group for the American Society for Quality, where she supports building the female leadership pipeline and building the future of success across various industries (automotive, aerospace, manufacturing, technology, etc.) Advocate and Gala Committee Member for the Tourette’s Association of America, Advocate for Make-A-Wish NJ and Powershift Ambassador for Shark Tank’s Daymond John.
Paul Frewer
Paul has been a statistician in the industry for over 25 years, working for Eli Lilly, GSK, Ipsen and AstraZeneca. His initial experiences were as a statistician on post-marketing studies and since then has slowly moved backwards through the phases to his current role in early clinical development.He has worked across most therapeutic areas and has specialized solely in oncology for the past 15 years. He joined AstraZeneca in 2012 and is now a Biometrics Team Leader in the Early Oncology Statistics team. He supports multiple different compounds in the oncology therapeutic area across many studies from Phase I up to Phase IIb. He has published on the AZ decision making framework and presented several times on the topic at conferences over the last few years.
Chrissie Fletcher
Chrissie is the Vice President of Speciality and Primary Care Statistics at GSK. She has worked in the Pharmaceutical Industry for over 30 years and has experience of developing and commercialising new medicines in a variety of clinical disease areas across all phases of clinical development. Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry such as driving innovation in clinical trials and sharing implementation experiences of the estimand framework. She is an advocate and champion for diversity, equity and inclusion where she supports a variety of Women Leadership programs.
PSI Training Course: Introduction to Machine Learning
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK